Chips, EVs, and Oil Dominate a Turbulent Monday
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Geopolitics Hits Energy
The Iran conflict is reverberating through energy markets. XOM is in focus after political criticism mounted over disruptions to Strait of Hormuz shipping. Oil price volatility is feeding through to US shale names. UBS raised its target on OXY to $67 and lifted FANG to $253. Both moves signal growing analyst confidence in US producers as a beneficiary of Middle East supply stress.
Bears Pile Into EVs and Semis
Short sellers are not letting up on troubled names. LCID short interest hit 49.7% of free float — up nearly 15 points in a week. WOLF sits at an extraordinary 83.7%, with zero shares available to borrow. Options traders are also defensive on chips. NVDA leads large-caps in bearish options flow. MU and AMD follow. The AI safety debate — Trump calling warnings a "hoax" while Obama backs a slowdown — adds political noise to an already jittery sector.
Insiders Sell, One COO Buys
Founders are cashing out. ESTC CTO Shay-Shalom Banon filed $44M in sales. argenx CEO filed a $21M exit at $908 per share. Against that tide, Uber President and COO Andrew MacDonald stepped in as a buyer — a contrarian signal worth watching.
Earnings Week Begins
Lennar reports Q3 results Tuesday with short interest at 10.1% of free float. Bears are positioned ahead of the print. UK housebuilder Barratt Redrow also reports this week. Both names give investors a read on housing demand across two continents. The Progressive Corporation drops August data Thursday — a key barometer for US auto insurance pricing.
Stocks in this article
How this article was generated
- Generated
- 15 Sept 2026, 04:50
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowORTEX Alpha signalsORTEX Alpha signalsAnalyst consensus
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.